(260) revealed that LINC00511 acted as a ceRNA, which contributed to breast cancer tumorigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis, whereas the LINC00511/miR-150/MMP13 ceRNA axis also promoted breast cancer proliferation, migration, and invasion (261). The gene discussed is NANOG; the disease is breast carcinoma.